
Pancreatic cancer stroma: an update on therapeutic targeting ... - Nature
2020年5月11日 · In this Review, we discuss our current understanding of the three principal constituents of PDAC stroma, their effect on the prevalent immune landscape and promising therapeutic targets within ...
Beyond just a tight fortress: contribution of stroma to epithelial ...
2020年10月30日 · It is increasing clear that the extensive fibro-inflammatory stroma (or desmoplasia) of PDAC plays an active role in the progression and therapeutic resistance of PDAC.
Stroma gene signature predicts responsiveness to chemotherapy …
2025年2月4日 · In summary, we identified a stroma gene signature that differentiates PDAC-PDXs that are responsive to gemcitabine plus Nab-paclitaxel treatment from those that are not, confirming the active role of the tumor microenvironment in the drug response.
Breaking the stromal barrier in pancreatic cancer: Advances and ...
2024年1月1日 · Drug resistance in PC is driven by its desmoplastic stroma, which creates a barrier that shields cancer niches and prevents the penetration of drugs. The PC stroma comprises heterogeneous cellular populations and non-cellular components involved in aberrant ECM deposition, immunosuppression, and drug resistance.
Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An …
2021年4月5日 · The PDAC immune microenvironment is characterized by the exhaustion of anti-cancer immune cytotoxic T lymphocytes notably due to high mechanical constraints within the tumor and the infiltration of multiple types of tumor-promoting immune cells, including myeloid-derived suppressor cells, tumor-associated macrophages and regulatory T cells (10 ...
Pancreatic cancer stroma: an update on therapeutic targeting ... - PubMed
Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related mortality in the Western world with limited therapeutic options and dismal long-term survival. The neoplastic epithelium exists within a dense stroma, which is recognized as a critical mediator of disease progression throug …
Targeting stromal metabolism in pancreatic ductal …
2024年3月1日 · New work finds that pancreatic ductal adenocarcinoma cells use one such nutrient, acetate, to alter protein acetylation, rerouting polyamine metabolism and promoting cell growth under acidosis—a...
Generation of an in vitro 3D PDAC stroma rich spheroid model
We have achieved this in vitro model by incorporating PSCs into 3D PDAC cell culture using a modified hanging drop method. It is now known that PSCs are the principal source of fibrosis in the stroma and interact closely with cancer cells to create a tumor facilitatory environment that stimulates local and distant tumor growth.
Incorporation of human iPSC-derived stromal cells creates a …
2023年11月28日 · In this study, we combined three culture technologies to generate a PDAC organoid that contained 3D epithelial structures and heterogeneous stromal cells without extrinsic ECM.
Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With …
The dense dysplastic stroma of PDAC is a major obstacle to the delivery of chemotherapy drugs and plays an important role in the progression of PDAC. Therefore, stroma-targeting therapy is considered a potential treatment strategy to improve the efficacy of …
- 某些结果已被删除